Teraflu Coated ExtraTab tablets # 10

Teraflu Extratab tab.

p / o film No. 10

Dosage

650mg + 10mg + 4mg

Structure

1 tablet contains: Active ingredients: paracetamol 650 mg, chlorphenamine maleate 4 mg, phenylephrine hydrochloride 10 mg.

Excipients: colloidal silicon dioxide - 0.4 mg, varnish based on quinoline yellow dye - 0.85 mg, lactose - 3.1 mg, magnesium stearate - 3.5 mg, hyprolose - 17 mg, croscarmellose sodium - 57 mg, corn starch - 124 mg.

The composition of the film shell: varnish based on quinoline yellow dye - 0.0331 mg, quinoline yellow dye - 0.0392 mg, titanium dioxide - 1.0882 mg, methyl parahydroxybenzoate - 0.0889 mg, povidone - 0.4353 mg, colloidal silicon dioxide - 0.6529 mg, macrogol 400 - 1.7412 mg , methylcellulose - 3.9176 mg.

Storage conditions and periods

At a temperature not higher than 25 degrees.

INN / Active ingredient

Chlorphenamine + Phenylephrine + Paracetamol

Specifications

Category

Pain and fever

Release form

Tablet

Manufacturer country

Turkey

Package quantity, pcs

ten

Vacation conditions

Without recipe

Brand name

Teraflu

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Dosage form

Film-coated tablets

A type

Medicine

The target audience

Children

Package weight, g

45

Dosage (volume) of the substance in the preparation

:

Paracetamol 650 mg, chlorphenamine maleate 4 mg, phenylephrine hydrochloride 10 mg

Mode of application

:

Is taken internally.

< br> Adults - 1-2 tab.

every 4-6 hours, but not more than 6 tablets / day.

< br> Children over 12 years old - 1 tab.

every 4-6 hours, but not more than 4 tablets / day.

< br> It is recommended to swallow the pill whole without chewing with water.

< br> The course of treatment should not exceed 7 days.

< br> If there is no relief of symptoms within 3 days after starting the drug, you should consult a doctor.

Pharmaco-therapeutic group

:

ARI and cold" symptoms remedy (analgesic non-narcotic drug + alpha-adrenergic agonist + H1-histamine receptor blocker)

Anatomical and therapeutic characteristics

:

N02BE51 Paracetamol, in combination with other drugs (excluding psychotropic drugs)

"